Editorial: tripartite motif 26 inhibits hepatitis B virus replication and its genetic polymorphism predicts response to interferon treatment-towards a better understanding of interferon responsiveness in chronic hepatitis B

Aliment Pharmacol Ther. 2022 Sep;56(6):1094-1095. doi: 10.1111/apt.17159.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use
  • Hepatitis B virus
  • Hepatitis B* / drug therapy
  • Hepatitis B, Chronic* / drug therapy
  • Hepatitis B, Chronic* / genetics
  • Humans
  • Interferons / pharmacology
  • Interferons / therapeutic use
  • Polymorphism, Genetic
  • Virus Replication

Substances

  • Antiviral Agents
  • Interferons